Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 260 articles:
HTML format
Text format



Single Articles


    January 2017
  1. HENNIKA T, Hu G, Olaciregui NG, Barton KL, et al
    Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models.
    PLoS One. 2017;12:e0169485.
    PubMed     Text format     Abstract available


  2. JONES JE, Esler WP, Patel R, Lanba A, et al
    Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.
    PLoS One. 2017;12:e0169566.
    PubMed     Text format     Abstract available


  3. CILIBRASI C, Riva G, Romano G, Cadamuro M, et al
    Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.
    PLoS One. 2017;12:e0169854.
    PubMed     Text format     Abstract available


  4. QIN H, Janowski M, Pearl MS, Malysz-Cymborska I, et al
    Rabbit Model of Human Gliomas: Implications for Intra-Arterial Drug Delivery.
    PLoS One. 2017;12:e0169656.
    PubMed     Text format     Abstract available


  5. EIDEL O, Burth S, Neumann JO, Kieslich PJ, et al
    Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology.
    PLoS One. 2017;12:e0169292.
    PubMed     Text format     Abstract available


  6. ESTEVE-CODINA A, Arpi O, Martinez-Garcia M, Pineda E, et al
    A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples.
    PLoS One. 2017;12:e0170632.
    PubMed     Text format     Abstract available


  7. DOMENIS R, Cesselli D, Toffoletto B, Bourkoula E, et al
    Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells.
    PLoS One. 2017;12:e0169932.
    PubMed     Text format     Abstract available


  8. LIU PC, Lu G, Deng Y, Wang CD, et al
    Inhibition of NF-kappaB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy.
    PLoS One. 2017;12:e0171157.
    PubMed     Text format     Abstract available


  9. LEE W, Lim S, Kim Y
    The role of myosin II in glioma invasion: A mathematical model.
    PLoS One. 2017;12:e0171312.
    PubMed     Text format     Abstract available


  10. HSIEH KL, Tsai RJ, Teng YC, Lo CM, et al
    Effect of a computer-aided diagnosis system on radiologists' performance in grading gliomas with MRI.
    PLoS One. 2017;12:e0171342.
    PubMed     Text format     Abstract available


  11. CHLAPEK P, Zitterbart K, Kren L, Filipova L, et al
    Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups.
    PLoS One. 2017;12:e0172552.
    PubMed     Text format     Abstract available


  12. HUBER T, Alber G, Bette S, Kaesmacher J, et al
    Progressive disease in glioblastoma: Benefits and limitations of semi-automated volumetry.
    PLoS One. 2017;12:e0173112.
    PubMed     Text format     Abstract available


  13. BROWN DV, Filiz G, Daniel PM, Hollande F, et al
    Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
    PLoS One. 2017;12:e0172791.
    PubMed     Text format     Abstract available


  14. POLLAK J, Rai KG, Funk CC, Arora S, et al
    Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
    PLoS One. 2017;12:e0172884.
    PubMed     Text format     Abstract available


  15. WINTHER TL, Torp SH
    DNA topoisomerase IIalpha and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.
    PLoS One. 2017;12:e0172316.
    PubMed     Text format     Abstract available


  16. XU W, Wang Q, Shao A, Xu B, et al
    The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0173430.
    PubMed     Text format     Abstract available


  17. JIA P, Li F, Gu W, Zhang W, et al
    Gab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation.
    PLoS One. 2017;12:e0173473.
    PubMed     Text format     Abstract available


  18. KAYA B, Goceri E, Becker A, Elder B, et al
    Automated fluorescent miscroscopic image analysis of PTBP1 expression in glioma.
    PLoS One. 2017;12:e0170991.
    PubMed     Text format     Abstract available


  19. LEE CC, Chen PH, Ho KH, Shih CM, et al
    The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.
    PLoS One. 2017;12:e0173890.
    PubMed     Text format     Abstract available


  20. CONNOLLY NP, Stokum JA, Schneider CS, Ozawa T, et al
    Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer.
    PLoS One. 2017;12:e0174557.
    PubMed     Text format     Abstract available


  21. SHERRY-LYNES MM, Sengupta S, Kulkarni S, Cochran BH, et al
    Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3.
    PLoS One. 2017;12:e0174775.
    PubMed     Text format     Abstract available


  22. HSU SY, Ou CY, Ho YN, Huang YH, et al
    Application of Surgical Apgar Score in intracranial meningioma surgery.
    PLoS One. 2017;12:e0174328.
    PubMed     Text format     Abstract available


  23. REIMER C, Deike K, Graf M, Reimer P, et al
    Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps.
    PLoS One. 2017;12:e0174620.
    PubMed     Text format     Abstract available


  24. ROGERS S, Hii H, Huang J, Ancliffe M, et al
    A novel technique of serial biopsy in mouse brain tumour models.
    PLoS One. 2017;12:e0175169.
    PubMed     Text format     Abstract available


  25. YANG L, Mu Y, Cui H, Liang Y, et al
    MiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma.
    PLoS One. 2017;12:e0174839.
    PubMed     Text format     Abstract available


  26. SUN L, Moritake T, Ito K, Matsumoto Y, et al
    Metabolic analysis of radioresistant medulloblastoma stem-like clones and potential therapeutic targets.
    PLoS One. 2017;12:e0176162.
    PubMed     Text format     Abstract available


  27. MERCURIO L, Cecchetti S, Ricci A, Pacella A, et al
    Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells.
    PLoS One. 2017;12:e0176108.
    PubMed     Text format     Abstract available


  28. SANCHEZ-DIAZ PC, Chang JC, Moses ES, Dao T, et al
    Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma.
    PLoS One. 2017;12:e0176879.
    PubMed     Text format     Abstract available


  29. YANG M, Guo W, Yang C, Tang J, et al
    Mobile phone use and glioma risk: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175136.
    PubMed     Text format     Abstract available


  30. HILL VK, Kim JS, James CD, Waldman T, et al
    Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing.
    PLoS One. 2017;12:e0176683.
    PubMed     Text format     Abstract available


  31. ERMINI L, Morganti E, Post A, Yeganeh B, et al
    Imaging mass spectrometry identifies prognostic ganglioside species in rodent intracranial transplants of glioma and medulloblastoma.
    PLoS One. 2017;12:e0176254.
    PubMed     Text format     Abstract available


  32. BENAVIDES-SERRATO A, Lee J, Holmes B, Landon KA, et al
    Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
    PLoS One. 2017;12:e0176599.
    PubMed     Text format     Abstract available


  33. RAUSCHERT I, Aldunate F, Preussner J, Arocena-Sutz M, et al
    Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells.
    PLoS One. 2017;12:e0175953.
    PubMed     Text format     Abstract available


  34. HOWE JR 6TH, Li ES, Streeter SE, Rahme GJ, et al
    MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation.
    PLoS One. 2017;12:e0177661.
    PubMed     Text format     Abstract available


  35. PETUSHKOVA NA, Zgoda VG, Pyatnitskiy MA, Larina OV, et al
    Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples.
    PLoS One. 2017;12:e0177427.
    PubMed     Text format     Abstract available


  36. SCHNEIDER T, Kuhne JF, Bittrich P, Schroeder J, et al
    Edema is not a reliable diagnostic sign to exclude small brain metastases.
    PLoS One. 2017;12:e0177217.
    PubMed     Text format     Abstract available


  37. BOOTH TC, Larkin TJ, Yuan Y, Kettunen MI, et al
    Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.
    PLoS One. 2017;12:e0176528.
    PubMed     Text format     Abstract available


    January 2016
  38. CHUANG MT, Liu YS, Tsai YS, Chen YC, et al
    Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
    PLoS One. 2016;11:e0141438.
    PubMed     Text format     Abstract available


  39. MUROSKI ME, Morshed RA, Cheng Y, Vemulkar T, et al
    Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment.
    PLoS One. 2016;11:e0145129.
    PubMed     Text format     Abstract available


  40. LI BT, Lou E, Hsu M, Yu HA, et al
    Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    PLoS One. 2016;11:e0146063.
    PubMed     Text format     Abstract available


  41. MEKKAOUI C, Metellus P, Kostis WJ, Martuzzi R, et al
    Diffusion Tensor Imaging in Patients with Glioblastoma Multiforme Using the Supertoroidal Model.
    PLoS One. 2016;11:e0146693.
    PubMed     Text format     Abstract available


  42. RAMAN F, Scribner E, Saut O, Wenger C, et al
    Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme.
    PLoS One. 2016;11:e0146617.
    PubMed     Text format     Abstract available


  43. PARISOT S, Darlix A, Baumann C, Zouaoui S, et al
    A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain.
    PLoS One. 2016;11:e0144200.
    PubMed     Text format     Abstract available


  44. ISHII A, Kimura T, Sadahiro H, Kawano H, et al
    Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in Glioblastoma.
    PLoS One. 2016;11:e0147366.
    PubMed     Text format     Abstract available


  45. YASUMOTO Y, Miyazaki H, Vaidyan LK, Kagawa Y, et al
    Inhibition of Fatty Acid Synthase Decreases Expression of Stemness Markers in Glioma Stem Cells.
    PLoS One. 2016;11:e0147717.
    PubMed     Text format     Abstract available


  46. FU Y, Ong LC, Ranganath SH, Zheng L, et al
    A Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model.
    PLoS One. 2016;11:e0148123.
    PubMed     Text format     Abstract available


  47. OUYANG M, White EE, Ren H, Guo Q, et al
    Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model.
    PLoS One. 2016;11:e0148139.
    PubMed     Text format     Abstract available


  48. SELINGEROVA I, Dolezelova H, Horova I, Katina S, et al
    Survival of Patients with Primary Brain Tumors: Comparison of Two Statistical Approaches.
    PLoS One. 2016;11:e0148733.
    PubMed     Text format     Abstract available


  49. BEYER S, von Bueren AO, Klautke G, Guckenberger M, et al
    A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015.
    PLoS One. 2016;11:e0148312.
    PubMed     Text format     Abstract available


  50. TEIXIDOR P, Arraez MA, Villalba G, Garcia R, et al
    Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study.
    PLoS One. 2016;11:e0149244.
    PubMed     Text format     Abstract available


  51. YOSHIMURA Y, Shiino A, Muraki K, Fukami T, et al
    Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor.
    PLoS One. 2016;11:e0149826.
    PubMed     Text format     Abstract available


  52. SELIGER C, Meier CR, Becker C, Jick SS, et al
    Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma.
    PLoS One. 2016;11:e0149293.
    PubMed     Text format     Abstract available


  53. WU T, Li Y, Liu B, Zhang S, et al
    Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway.
    PLoS One. 2016;11:e0149361.
    PubMed     Text format     Abstract available


  54. CHEN YM, Lai CH, Chang HC, Chao TY, et al
    Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    PLoS One. 2016;11:e0149722.
    PubMed     Text format     Abstract available


  55. MORRISON MA, Churchill NW, Cusimano MD, Schweizer TA, et al
    Reliability of Task-Based fMRI for Preoperative Planning: A Test-Retest Study in Brain Tumor Patients and Healthy Controls.
    PLoS One. 2016;11:e0149547.
    PubMed     Text format     Abstract available


  56. ZHAO Q, Qin Q, Sun J, Han D, et al
    Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.
    PLoS One. 2016;11:e0150419.
    PubMed     Text format     Abstract available


  57. MOINFAR Z, Dambach H, Schoenebeck B, Forster E, et al
    Estradiol Receptors Regulate Differential Connexin 43 Expression in F98 and C6 Glioma Cell Lines.
    PLoS One. 2016;11:e0150007.
    PubMed     Text format     Abstract available


  58. LEUTHARDT EC, Duan C, Kim MJ, Campian JL, et al
    Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier.
    PLoS One. 2016;11:e0148613.
    PubMed     Text format     Abstract available


  59. GUICHET PO, Guelfi S, Ripoll C, Teigell M, et al
    Asymmetric Distribution of GFAP in Glioma Multipotent Cells.
    PLoS One. 2016;11:e0151274.
    PubMed     Text format     Abstract available


  60. SINGH AR, Joshi S, Zulcic M, Alcaraz M, et al
    PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
    PLoS One. 2016;11:e0150836.
    PubMed     Text format     Abstract available


  61. CAI Y, Wu J, Li Z, Long Q, et al
    Mathematical Modelling of a Brain Tumour Initiation and Early Development: A Coupled Model of Glioblastoma Growth, Pre-Existing Vessel Co-Option, Angiogenesis and Blood Perfusion.
    PLoS One. 2016;11:e0150296.
    PubMed     Text format     Abstract available


  62. MOECKEL S, Vollmann-Zwerenz A, Proescholdt M, Brawanski A, et al
    Validation Study: Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro.
    PLoS One. 2016;11:e0151312.
    PubMed     Text format     Abstract available



  63. Correction: Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    PLoS One. 2016;11:e0152450.
    PubMed     Text format     Abstract available


  64. WANG Y, Xing D, Zhao M, Wang J, et al
    The Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic Review.
    PLoS One. 2016;11:e0152170.
    PubMed     Text format     Abstract available


  65. BINDER ZA, Wilson KM, Salmasi V, Orr BA, et al
    Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines.
    PLoS One. 2016;11:e0150271.
    PubMed     Text format     Abstract available


  66. LI Q, Chen B, Cai J, Sun Y, et al
    Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.
    PLoS One. 2016;11:e0151815.
    PubMed     Text format     Abstract available


  67. OH SA, Yea JW, Kang MK, Park JW, et al
    Analysis of the Setup Uncertainty and Margin of the Daily ExacTrac 6D Image Guide System for Patients with Brain Tumors.
    PLoS One. 2016;11:e0151709.
    PubMed     Text format     Abstract available


  68. MACDIARMID JA, Langova V, Bailey D, Pattison ST, et al
    Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model.
    PLoS One. 2016;11:e0151832.
    PubMed     Text format     Abstract available


  69. HU J, Wu W, Zhu B, Wang H, et al
    Cerebral Glioma Grading Using Bayesian Network with Features Extracted from Multiple Modalities of Magnetic Resonance Imaging.
    PLoS One. 2016;11:e0153369.
    PubMed     Text format     Abstract available


  70. BASSOY EY, Chiusolo V, Jacquemin G, Riccadonna C, et al
    Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.
    PLoS One. 2016;11:e0153433.
    PubMed     Text format     Abstract available


  71. DUHRSEN L, Emami P, Matschke J, Abboud T, et al
    Meninigiomas of the Craniocervical Junction - A Distinctive Subgroup of Meningiomas.
    PLoS One. 2016;11:e0153405.
    PubMed     Text format     Abstract available


  72. SCHULTEN HJ, Hussein D, Al-Adwani F, Karim S, et al
    Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression.
    PLoS One. 2016;11:e0153681.
    PubMed     Text format     Abstract available


  73. ZHANG M, Hutter G, Kahn SA, Azad TD, et al
    Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.
    PLoS One. 2016;11:e0153550.
    PubMed     Text format     Abstract available


  74. LU J, Cowperthwaite MC, Burnett MG, Shpak M, et al
    Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
    PLoS One. 2016;11:e0154313.
    PubMed     Text format     Abstract available


  75. GAELZER MM, Coelho BP, de Quadros AH, Hoppe JB, et al
    Phosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low Neurotoxicity.
    PLoS One. 2016;11:e0154612.
    PubMed     Text format     Abstract available


  76. CHOI J, Kim JW, Keum YS, Lee IJ, et al
    The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups.
    PLoS One. 2016;11:e0154739.
    PubMed     Text format     Abstract available


  77. MUNTHE S, Petterson SA, Dahlrot RH, Poulsen FR, et al
    Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype.
    PLoS One. 2016;11:e0155106.
    PubMed     Text format     Abstract available


  78. APRELIKOVA O, Tomlinson CC, Hoenerhoff M, Hixon JA, et al
    Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
    PLoS One. 2016;11:e0155262.
    PubMed     Text format     Abstract available


  79. BROWN N, McBain C, Nash S, Hopkins K, et al
    Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.
    PLoS One. 2016;11:e0156369.
    PubMed     Text format     Abstract available


  80. TOGAO O, Hiwatashi A, Keupp J, Yamashita K, et al
    Amide Proton Transfer Imaging of Diffuse Gliomas: Effect of Saturation Pulse Length in Parallel Transmission-Based Technique.
    PLoS One. 2016;11:e0155925.
    PubMed     Text format     Abstract available


  81. GUGGER A, Barnhill RL, Seifert B, Dehler S, et al
    Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations.
    PLoS One. 2016;11:e0156115.
    PubMed     Text format     Abstract available


  82. HU J, Wu W, Zhu B, Wang H, et al
    Correction: Cerebral Glioma Grading Using Bayesian Network with Features Extracted from Multiple Modalities of Magnetic Resonance Imaging.
    PLoS One. 2016;11:e0157095.
    PubMed     Text format     Abstract available


  83. LOHKAMP LN, Schinz M, Gehlhaar C, Guse K, et al
    MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma.
    PLoS One. 2016;11:e0156422.
    PubMed     Text format     Abstract available


  84. BURGER MC, Zeiner PS, Jahnke K, Wagner M, et al
    Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors.
    PLoS One. 2016;11:e0155315.
    PubMed     Text format     Abstract available


  85. PAPIN-MICHAULT C, Bonnetaud C, Dufour M, Almairac F, et al
    Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers.
    PLoS One. 2016;11:e0157139.
    PubMed     Text format     Abstract available


  86. CHENG J, Yang W, Huang M, Huang W, et al
    Retrieval of Brain Tumors by Adaptive Spatial Pooling and Fisher Vector Representation.
    PLoS One. 2016;11:e0157112.
    PubMed     Text format     Abstract available


  87. SHACKLEFORD GM, Shi XH, Swanson KS, Mahdi MY, et al
    BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
    PLoS One. 2016;11:e0156907.
    PubMed     Text format     Abstract available


  88. CUI Y, Zhao J, Yi L, Jiang Y, et al
    microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells.
    PLoS One. 2016;11:e0156915.
    PubMed     Text format     Abstract available


  89. PESSINA F, Navarria P, Cozzi L, Ascolese AM, et al
    Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases.
    PLoS One. 2016;11:e0157869.
    PubMed     Text format     Abstract available


  90. CHAKRABARTI M, Klionsky DJ, Ray SK
    miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells.
    PLoS One. 2016;11:e0158537.
    PubMed     Text format     Abstract available


  91. PUIG J, Sanchez-Gonzalez J, Blasco G, Daunis-I-Estadella P, et al
    Intravoxel Incoherent Motion Metrics as Potential Biomarkers for Survival in Glioblastoma.
    PLoS One. 2016;11:e0158887.
    PubMed     Text format     Abstract available


  92. BASSANI B, Bartolini D, Pagani A, Principi E, et al
    Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/beta-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
    PLoS One. 2016;11:e0154111.
    PubMed     Text format     Abstract available


  93. HEO H, Kim S, Lee HH, Cho HR, et al
    On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel.
    PLoS One. 2016;11:e0147794.
    PubMed     Text format     Abstract available


  94. VERA B, Martinez-Velez N, Xipell E, Acanda de la Rocha A, et al
    Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01.
    PLoS One. 2016;11:e0147211.
    PubMed     Text format     Abstract available


  95. ZHANG H, Zhang P, Fan J, Qiu B, et al
    Determining an Optimal Cutoff of Serum beta-Human Chorionic Gonadotropin for Assisting the Diagnosis of Intracranial Germinomas.
    PLoS One. 2016;11:e0147023.
    PubMed     Text format     Abstract available


  96. LIANG S, Zhang J, Zhang S, Fu X, et al
    Epilepsy in Adults with Supratentorial Glioblastoma: Incidence and Influence Factors and Prophylaxis in 184 Patients.
    PLoS One. 2016;11:e0158206.
    PubMed     Text format     Abstract available


  97. MATHUPALA SP, Kiousis S, Szerlip NJ
    A Lab Assembled Microcontroller-Based Sensor Module for Continuous Oxygen Measurement in Portable Hypoxia Chambers.
    PLoS One. 2016;11:e0148923.
    PubMed     Text format     Abstract available


  98. RYU JA, Bang OY, Suh GY, Yang JH, et al
    Ischemic Stroke in Critically Ill Patients with Malignancy.
    PLoS One. 2016;11:e0146836.
    PubMed     Text format     Abstract available


  99. EIDEL O, Neumann JO, Burth S, Kieslich PJ, et al
    Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting.
    PLoS One. 2016;11:e0160250.
    PubMed     Text format     Abstract available


  100. PAL D, Mukhopadhyay D, Ramaiah MJ, Sarma P, et al
    Regulation of Cell Proliferation and Migration by miR-203 via GAS41/miR-10b Axis in Human Glioblastoma Cells.
    PLoS One. 2016;11:e0159092.
    PubMed     Text format     Abstract available


  101. DE LUCAS AG, Schuhmacher AJ, Oteo M, Romero E, et al
    Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas.
    PLoS One. 2016;11:e0158634.
    PubMed     Text format     Abstract available


  102. STANGHERLIN LM, Castro FL, Medeiros RS, Guerra JM, et al
    Human Cytomegalovirus DNA Quantification and Gene Expression in Gliomas of Different Grades.
    PLoS One. 2016;11:e0159604.
    PubMed     Text format     Abstract available



  103. Retraction: Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway.
    PLoS One. 2016;11:e0160194.
    PubMed     Text format    


  104. JENSEN SS, Meyer M, Petterson SA, Halle B, et al
    Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model.
    PLoS One. 2016;11:e0159746.
    PubMed     Text format     Abstract available


  105. MITTRA ES, Koglin N, Mosci C, Kumar M, et al
    Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
    PLoS One. 2016;11:e0148628.
    PubMed     Text format     Abstract available


  106. VERMEULEN JF, van Hecke W, Spliet WG, Villacorta Hidalgo J, et al
    Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors.
    PLoS One. 2016;11:e0151465.
    PubMed     Text format     Abstract available


  107. HACKLER L JR, Ozsvari B, Gyuris M, Sipos P, et al
    The Curcumin Analog C-150, Influencing NF-kappaB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo.
    PLoS One. 2016;11:e0149832.
    PubMed     Text format     Abstract available


  108. TREIBER JM, White NS, Steed TC, Bartsch H, et al
    Characterization and Correction of Geometric Distortions in 814 Diffusion Weighted Images.
    PLoS One. 2016;11:e0152472.
    PubMed     Text format     Abstract available


  109. JIANG H, Liu W, Zhan SK, Pan YX, et al
    GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings.
    PLoS One. 2016;11:e0161017.
    PubMed     Text format     Abstract available


  110. HATAE R, Hata N, Yoshimoto K, Kuga D, et al
    Precise Detection of IDH1/2 and BRAF Hotspot Mutations in Clinical Glioma Tissues by a Differential Calculus Analysis of High-Resolution Melting Data.
    PLoS One. 2016;11:e0160489.
    PubMed     Text format     Abstract available


  111. XU T, Le TD, Liu L, Wang R, et al
    Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data.
    PLoS One. 2016;11:e0152792.
    PubMed     Text format     Abstract available


  112. TELLAROLI P, Bazzi M, Donato M, Brazzale AR, et al
    Cross-Clustering: A Partial Clustering Algorithm with Automatic Estimation of the Number of Clusters.
    PLoS One. 2016;11:e0152333.
    PubMed     Text format     Abstract available


  113. MALO CS, Renner DN, Huseby Kelcher AM, Jin F, et al
    The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma.
    PLoS One. 2016;11:e0162064.
    PubMed     Text format     Abstract available


  114. BOLCAEN J, Lybaert K, Moerman L, Descamps B, et al
    Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
    PLoS One. 2016;11:e0161845.
    PubMed     Text format     Abstract available


  115. MOLINA D, Perez-Beteta J, Martinez-Gonzalez A, Sepulveda JM, et al
    Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.
    PLoS One. 2016;11:e0161484.
    PubMed     Text format     Abstract available


  116. HUANG D, Lin C, Wen X, Gu S, et al
    A Potential Nanofiber Membrane Device for Filling Surgical Residual Cavity to Prevent Glioma Recurrence and Improve Local Neural Tissue Reconstruction.
    PLoS One. 2016;11:e0161435.
    PubMed     Text format     Abstract available


  117. CHEN SM, Li YY, Tu CH, Salazar N, et al
    Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.
    PLoS One. 2016;11:e0161299.
    PubMed     Text format     Abstract available


  118. RICCADONNA C, Yacoub Maroun C, Vuillefroy de Silly R, Boehler M, et al
    Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing.
    PLoS One. 2016;11:e0162105.
    PubMed     Text format     Abstract available


  119. KANONIDIS EI, Roy MM, Deighton RF, Le Bihan T, et al
    Protein Co-Expression Analysis as a Strategy to Complement a Standard Quantitative Proteomics Approach: Case of a Glioblastoma Multiforme Study.
    PLoS One. 2016;11:e0161828.
    PubMed     Text format     Abstract available


  120. MARTINEZ NJ, Rai G, Yasgar A, Lea WA, et al
    A High-Throughput Screen Identifies 2,9-Diazaspiro[5.5]Undecanes as Inducers of the Endoplasmic Reticulum Stress Response with Cytotoxic Activity in 3D Glioma Cell Models.
    PLoS One. 2016;11:e0161486.
    PubMed     Text format     Abstract available


  121. QI Q, Yeung TP, Lee TY, Bauman G, et al
    Evaluation of CT Perfusion Biomarkers of Tumor Hypoxia.
    PLoS One. 2016;11:e0153569.
    PubMed     Text format     Abstract available


  122. CHOI SH, Kim SH, Shim KW, Han JW, et al
    Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.
    PLoS One. 2016;11:e0153443.
    PubMed     Text format     Abstract available


  123. KO CC, Tai MH, Li CF, Chen TY, et al
    Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
    PLoS One. 2016;11:e0162565.
    PubMed     Text format     Abstract available


  124. JARMUSCH AK, Alfaro CM, Pirro V, Hattab EM, et al
    Differential Lipid Profiles of Normal Human Brain Matter and Gliomas by Positive and Negative Mode Desorption Electrospray Ionization - Mass Spectrometry Imaging.
    PLoS One. 2016;11:e0163180.
    PubMed     Text format     Abstract available


  125. MIN W, Dai D, Wang J, Zhang D, et al
    Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma.
    PLoS One. 2016;11:e0160451.
    PubMed     Text format     Abstract available


  126. KINOSHITA M, Sakai M, Arita H, Shofuda T, et al
    Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas.
    PLoS One. 2016;11:e0164268.
    PubMed     Text format     Abstract available


  127. YE H, Huang H, Cao F, Chen M, et al
    HSPB1 Enhances SIRT2-Mediated G6PD Activation and Promotes Glioma Cell Proliferation.
    PLoS One. 2016;11:e0164285.
    PubMed     Text format     Abstract available


  128. HICKS MJ, Chiuchiolo MJ, Ballon D, Dyke JP, et al
    Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma.
    PLoS One. 2016;11:e0162978.
    PubMed     Text format     Abstract available


  129. KORSHOEJ AR, Saturnino GB, Rasmussen LK, von Oettingen G, et al
    Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study.
    PLoS One. 2016;11:e0164051.
    PubMed     Text format     Abstract available


  130. BOLCAEN J, Lybaert K, Moerman L, Descamps B, et al
    Correction: Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
    PLoS One. 2016;11:e0164208.
    PubMed     Text format     Abstract available


  131. SAGARA A, Igarashi K, Otsuka M, Karasawa T, et al
    Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR.
    PLoS One. 2016;11:e0164250.
    PubMed     Text format     Abstract available


  132. YE R, Shen T, Jiang Y, Xu L, et al
    The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis.
    PLoS One. 2016;11:e0164388.
    PubMed     Text format     Abstract available


  133. FREITAG MT, Maier-Hein KH, Binczyk F, Laun FB, et al
    Early Detection of Malignant Transformation in Resected WHO II Low-Grade Glioma Using Diffusion Tensor-Derived Quantitative Measures.
    PLoS One. 2016;11:e0164679.
    PubMed     Text format     Abstract available


  134. LEMAIRE L, Nel J, Franconi F, Bastiat G, et al
    Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO2 on In Vitro Expansion Conditions.
    PLoS One. 2016;11:e0165479.
    PubMed     Text format     Abstract available


  135. SUFIT A, Lee-Sherick AB, DeRyckere D, Rupji M, et al
    MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme.
    PLoS One. 2016;11:e0165107.
    PubMed     Text format     Abstract available


  136. FYLLINGEN EH, Stensjoen AL, Berntsen EM, Solheim O, et al
    Glioblastoma Segmentation: Comparison of Three Different Software Packages.
    PLoS One. 2016;11:e0164891.
    PubMed     Text format     Abstract available


  137. DAHLIN AM, Wibom C, Ghasimi S, Brannstrom T, et al
    Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
    PLoS One. 2016;11:e0163067.
    PubMed     Text format     Abstract available


  138. LUM MA, Martin AJ, Alexander MD, McCoy DB, et al
    Intra-Arterial MR Perfusion Imaging of Meningiomas: Comparison to Digital Subtraction Angiography and Intravenous MR Perfusion Imaging.
    PLoS One. 2016;11:e0163554.
    PubMed     Text format     Abstract available


  139. JANISZEWSKA J, Posadas I, Jativa P, Bugaj-Zarebska M, et al
    Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes.
    PLoS One. 2016;11:e0165704.
    PubMed     Text format     Abstract available


  140. KIRSCHNER S, Murle B, Felix M, Arns A, et al
    Imaging of Orthotopic Glioblastoma Xenografts in Mice Using a Clinical CT Scanner: Comparison with Micro-CT and Histology.
    PLoS One. 2016;11:e0165994.
    PubMed     Text format     Abstract available


  141. MARTINEZ NJ, Rai G, Yasgar A, Lea WA, et al
    Correction: A High-Throughput Screen Identifies 2,9-Diazaspiro[5.5]Undecanes as Inducers of the Endoplasmic Reticulum Stress Response with Cytotoxic Activity in 3D Glioma Cell Models.
    PLoS One. 2016;11:e0166506.
    PubMed     Text format     Abstract available


  142. CRISMAN TJ, Zelaya I, Laks DR, Zhao Y, et al
    Identification of an Efficient Gene Expression Panel for Glioblastoma Classification.
    PLoS One. 2016;11:e0164649.
    PubMed     Text format     Abstract available


  143. KIM BR, Choi SH, Yun TJ, Lee ST, et al
    MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction.
    PLoS One. 2016;11:e0166096.
    PubMed     Text format     Abstract available


  144. SUNWOO L, Yun TJ, You SH, Yoo RE, et al
    Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging.
    PLoS One. 2016;11:e0166662.
    PubMed     Text format     Abstract available


  145. DEUSCHL C, Goericke S, Grueneisen J, Sawicki LM, et al
    Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors.
    PLoS One. 2016;11:e0167596.
    PubMed     Text format     Abstract available


  146. CHENG Y, Zhao G, Zhang S, Nigim F, et al
    AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
    PLoS One. 2016;11:e0167094.
    PubMed     Text format     Abstract available


  147. WESTON C, Klobusicky J, Weston J, Connor J, et al
    Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas.
    PLoS One. 2016;11:e0166593.
    PubMed     Text format     Abstract available


  148. CHEN PH, Cheng CH, Shih CM, Ho KH, et al
    The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
    PLoS One. 2016;11:e0167096.
    PubMed     Text format     Abstract available


  149. YAMAGUCHI S, Hirata K, Toyonaga T, Kobayashi K, et al
    Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
    PLoS One. 2016;11:e0167917.
    PubMed     Text format     Abstract available


  150. ZHANG I, Alizadeh D, Liang J, Zhang L, et al
    Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages.
    PLoS One. 2016;11:e0165118.
    PubMed     Text format     Abstract available


  151. GILDER AS, Wang L, Natali L, Karimi-Mostowfi N, et al
    Pertussis Toxin Is a Robust and Selective Inhibitor of High Grade Glioma Cell Migration and Invasion.
    PLoS One. 2016;11:e0168418.
    PubMed     Text format     Abstract available


  152. SHIMIZU M, Tanaka M, Atomi Y
    Small Heat Shock Protein alphaB-Crystallin Controls Shape and Adhesion of Glioma and Myoblast Cells in the Absence of Stress.
    PLoS One. 2016;11:e0168136.
    PubMed     Text format     Abstract available


  153. KROGH PETERSEN J, Jensen P, Dahl Sorensen M, Winther Kristensen B, et al
    Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
    PLoS One. 2016;11:e0169129.
    PubMed     Text format     Abstract available


  154. STEIDL E, Pilatus U, Hattingen E, Steinbach JP, et al
    Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.
    PLoS One. 2016;11:e0168113.
    PubMed     Text format     Abstract available


  155. HUHNDORF M, Moussavi A, Kramann N, Will O, et al
    Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model.
    PLoS One. 2016;11:e0168174.
    PubMed     Text format     Abstract available


  156. LI Y, Hou M, Lu G, Ciccone N, et al
    The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0168264.
    PubMed     Text format     Abstract available


  157. WEN G, Tang C, Zhong C, Li X, et al
    Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0153397.
    PubMed     Text format     Abstract available


  158. LIU S, Wang Y, Fan X, Ma J, et al
    Anatomical Involvement of the Subventricular Zone Predicts Poor Survival Outcome in Low-Grade Astrocytomas.
    PLoS One. 2016;11:e0154539.
    PubMed     Text format     Abstract available


    January 2015
  159. FAN SY, Jiang JD, Qian J, Lu YC, et al
    Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence.
    PLoS One. 2015;10:e0125661.
    PubMed     Text format     Abstract available


  160. HARTER PN, Jennewein L, Baumgarten P, Ilina E, et al
    Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors.
    PLoS One. 2015;10:e0127123.
    PubMed     Text format     Abstract available


  161. BERGHAUSER PONT LM, Kleijn A, Kloezeman JJ, van den Bossche W, et al
    The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.
    PLoS One. 2015;10:e0127058.
    PubMed     Text format     Abstract available


  162. ABDULLAH KG, Ramayya A, Thawani JP, Macyszyn L, et al
    Factors associated with increased survival after surgical resection of glioblastoma in octogenarians.
    PLoS One. 2015;10:e0127202.
    PubMed     Text format     Abstract available


  163. CAI J, Zhang W, Yang P, Wang Y, et al
    Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring m2 microglia/macrophage phenotype relevance.
    PLoS One. 2015;10:e0126022.
    PubMed     Text format     Abstract available


  164. JUAN-ALBARRACIN J, Fuster-Garcia E, Manjon JV, Robles M, et al
    Automated glioblastoma segmentation based on a multiparametric structured unsupervised classification.
    PLoS One. 2015;10:e0125143.
    PubMed     Text format     Abstract available


  165. DU W, Pang C, Wang D, Zhang Q, et al
    Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas.
    PLoS One. 2015;10:e0127976.
    PubMed     Text format     Abstract available


  166. LI KK, Qi Y, Xia T, Yao Y, et al
    CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1.
    PLoS One. 2015;10:e0127910.
    PubMed     Text format     Abstract available


  167. YOSHIMURA Y, Shiino A, Muraki K, Fukami T, et al
    Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.
    PLoS One. 2015;10:e0128288.
    PubMed     Text format     Abstract available


  168. G B, Arfuso F, Millward M, Dharmarajan A, et al
    Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties.
    PLoS One. 2015;10:e0127517.
    PubMed     Text format     Abstract available


  169. MINAMI H, Tashiro K, Okada A, Hirata N, et al
    Generation of Brain Microvascular Endothelial-Like Cells from Human Induced Pluripotent Stem Cells by Co-Culture with C6 Glioma Cells.
    PLoS One. 2015;10:e0128890.
    PubMed     Text format     Abstract available


  170. CHIEN LN, Ostrom QT, Gittleman H, Lin JW, et al
    International Differences in Treatment and Clinical Outcomes for High Grade Glioma.
    PLoS One. 2015;10:e0129602.
    PubMed     Text format     Abstract available


  171. ZINDY F, Lee Y, Kawauchi D, Ayrault O, et al
    Dicer Is Required for Normal Cerebellar Development and to Restrain Medulloblastoma Formation.
    PLoS One. 2015;10:e0129642.
    PubMed     Text format     Abstract available


  172. BARRANTES-FREER A, Renovanz M, Eich M, Braukmann A, et al
    CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
    PLoS One. 2015;10:e0130519.
    PubMed     Text format     Abstract available


  173. WOOLF EC, Curley KL, Liu Q, Turner GH, et al
    The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model.
    PLoS One. 2015;10:e0130357.
    PubMed     Text format     Abstract available


  174. SIU A, Volotskova O, Cheng X, Khalsa SS, et al
    Differential Effects of Cold Atmospheric Plasma in the Treatment of Malignant Glioma.
    PLoS One. 2015;10:e0126313.
    PubMed     Text format     Abstract available


  175. CHOI SA, Lee JY, Kwon SE, Wang KC, et al
    Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells.
    PLoS One. 2015;10:e0129292.
    PubMed     Text format     Abstract available


  176. DE MELO SM, Bittencourt S, Ferrazoli EG, da Silva CS, et al
    The Anti-Tumor Effects of Adipose Tissue Mesenchymal Stem Cell Transduced with HSV-Tk Gene on U-87-Driven Brain Tumor.
    PLoS One. 2015;10:e0128922.
    PubMed     Text format     Abstract available


  177. ATIF F, Patel NR, Yousuf S, Stein DG, et al
    The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.
    PLoS One. 2015;10:e0131441.
    PubMed     Text format     Abstract available


  178. RAKOTONJANAHARY J, De Carli E, Delion M, Kalifa C, et al
    Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.
    PLoS One. 2015;10:e0127676.
    PubMed     Text format     Abstract available


  179. ROLON-REYES K, Kucheryavykh YV, Cubano LA, Inyushin M, et al
    Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway.
    PLoS One. 2015;10:e0131059.
    PubMed     Text format     Abstract available


  180. XIA Z, Liu F, Zhang J, Liu L, et al
    Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion.
    PLoS One. 2015;10:e0132399.
    PubMed     Text format     Abstract available


  181. FURUKAWA JI, Tsuda M, Okada K, Kimura T, et al
    Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to Malignancy.
    PLoS One. 2015;10:e0128300.
    PubMed     Text format     Abstract available


  182. STROBELE S, Schneider M, Schneele L, Siegelin MD, et al
    A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
    PLoS One. 2015;10:e0131670.
    PubMed     Text format     Abstract available


  183. COBURGER J, Hagel V, Wirtz CR, Konig R, et al
    Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
    PLoS One. 2015;10:e0131872.
    PubMed     Text format     Abstract available


  184. LI MY, Wang YY, Cai JQ, Zhang CB, et al
    Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
    PLoS One. 2015;10:e0130872.
    PubMed     Text format     Abstract available


  185. KING TZ, Wang L, Mao H
    Disruption of White Matter Integrity in Adult Survivors of Childhood Brain Tumors: Correlates with Long-Term Intellectual Outcomes.
    PLoS One. 2015;10:e0131744.
    PubMed     Text format     Abstract available


  186. COLOMBO MC, Giverso C, Faggiano E, Boffano C, et al
    Towards the Personalized Treatment of Glioblastoma: Integrating Patient-Specific Clinical Data in a Continuous Mechanical Model.
    PLoS One. 2015;10:e0132887.
    PubMed     Text format     Abstract available


  187. ARSHAD A, Yang B, Bienemann AS, Barua NU, et al
    Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma.
    PLoS One. 2015;10:e0132266.
    PubMed     Text format     Abstract available


  188. TILSON SG, Haley EM, Triantafillu UL, Dozier DA, et al
    ROCK Inhibition Facilitates In Vitro Expansion of Glioblastoma Stem-Like Cells.
    PLoS One. 2015;10:e0132823.
    PubMed     Text format     Abstract available


  189. MINAMIMOTO R, Saginoya T, Kondo C, Tomura N, et al
    Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment.
    PLoS One. 2015;10:e0132515.
    PubMed     Text format     Abstract available


  190. AMELOT A, De Cremoux P, Quillien V, Polivka M, et al
    IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients.
    PLoS One. 2015;10:e0130596.
    PubMed     Text format     Abstract available


  191. TSANG SY, Mei L, Wan W, Li J, et al
    Glioma Association and Balancing Selection of ZFPM2.
    PLoS One. 2015;10:e0133003.
    PubMed     Text format     Abstract available


  192. DANG MT, Wehrli S, Dang CV, Curran T, et al
    The Ketogenic Diet Does Not Affect Growth of Hedgehog Pathway Medulloblastoma in Mice.
    PLoS One. 2015;10:e0133633.
    PubMed     Text format     Abstract available


  193. FARACE C, Oliver JA, Melguizo C, Alvarez P, et al
    Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
    PLoS One. 2015;10:e0134111.
    PubMed     Text format     Abstract available



  194. Correction: A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
    PLoS One. 2015;10:e0134770.
    PubMed     Text format     Abstract available


  195. SHIM WH, Kim HS, Choi CG, Kim SJ, et al
    Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion for Differentiating among Glioblastoma, Metastasis, and Lymphoma Focusing on Diffusion-Related Parameter.
    PLoS One. 2015;10:e0134761.
    PubMed     Text format     Abstract available


  196. CHOI SA, Lee JY, Kwon SE, Wang KC, et al
    Correction: Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells.
    PLoS One. 2015;10:e0132877.
    PubMed     Text format     Abstract available


  197. LIU Y, Liu Y, Sun C, Gan L, et al
    Correction: Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF.
    PLoS One. 2015;10:e0135508.
    PubMed     Text format     Abstract available


  198. THOMAS AG, Sattler R, Tendyke K, Loiacono KA, et al
    High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
    PLoS One. 2015;10:e0127785.
    PubMed     Text format     Abstract available


  199. APTEKAR S, Arora M, Lawrence CL, Lea RW, et al
    Selective Targeting to Glioma with Nucleic Acid Aptamers.
    PLoS One. 2015;10:e0134957.
    PubMed     Text format     Abstract available


  200. COUTINHO DE SOUZA P, Mallory S, Smith N, Saunders D, et al
    Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.
    PLoS One. 2015;10:e0134276.
    PubMed     Text format     Abstract available


  201. ZENIOU M, Feve M, Mameri S, Dong J, et al
    Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.
    PLoS One. 2015;10:e0134793.
    PubMed     Text format     Abstract available


  202. HUANG BY, Zhan YP, Zong WJ, Yu CJ, et al
    The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells.
    PLoS One. 2015;10:e0134715.
    PubMed     Text format     Abstract available


  203. KIM SH, Adhikari BB, Cruz S, Schramm MP, et al
    Targeted Intracellular Delivery of Resveratrol to Glioblastoma Cells Using Apolipoprotein E-Containing Reconstituted HDL as a Nanovehicle.
    PLoS One. 2015;10:e0135130.
    PubMed     Text format     Abstract available


  204. HUSZTHY PC, Sakariassen PO, Espedal H, Brokstad KA, et al
    Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.
    PLoS One. 2015;10:e0136089.
    PubMed     Text format     Abstract available


  205. SUGIMORI M, Hayakawa Y, Boman BM, Fields JZ, et al
    Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations.
    PLoS One. 2015;10:e0135760.
    PubMed     Text format     Abstract available


  206. SHANNON S, Vaca C, Jia D, Entersz I, et al
    Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells.
    PLoS One. 2015;10:e0135951.
    PubMed     Text format     Abstract available


  207. BARCISZEWSKA AM, Gurda D, Glodowicz P, Nowak S, et al
    A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells.
    PLoS One. 2015;10:e0136669.
    PubMed     Text format     Abstract available


  208. HEO YJ, Kim HS, Park JE, Choi CG, et al
    Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
    PLoS One. 2015;10:e0136380.
    PubMed     Text format     Abstract available


  209. SERGENTANIS TN, Tsivgoulis G, Perlepe C, Ntanasis-Stathopoulos I, et al
    Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis.
    PLoS One. 2015;10:e0136974.
    PubMed     Text format     Abstract available


  210. YOO DH, Song SW, Yun TJ, Kim TM, et al
    MR Imaging Evaluation of Intracerebral Hemorrhages and T2 Hyperintense White Matter Lesions Appearing after Radiation Therapy in Adult Patients with Primary Brain Tumors.
    PLoS One. 2015;10:e0136795.
    PubMed     Text format     Abstract available


  211. SCHWARTZBAUM J, Seweryn M, Holloman C, Harris R, et al
    Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.
    PLoS One. 2015;10:e0137503.
    PubMed     Text format     Abstract available


  212. ZHAO J, Yang ZY, Luo BN, Yang JY, et al
    Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced MR in Tumor Parenchyma and Peritumoral Area for Distinction of Brain Tumors.
    PLoS One. 2015;10:e0138573.
    PubMed     Text format     Abstract available


  213. LEE J, Narang S, Martinez J, Rao G, et al
    Spatial Habitat Features Derived from Multiparametric Magnetic Resonance Imaging Data Are Associated with Molecular Subtype and 12-Month Survival Status in Glioblastoma Multiforme.
    PLoS One. 2015;10:e0136557.
    PubMed     Text format     Abstract available


  214. DOU W, Zhang M, Zhang X, Li Y, et al
    Convex-Envelope Based Automated Quantitative Approach to Multi-Voxel 1H-MRS Applied to Brain Tumor Analysis.
    PLoS One. 2015;10:e0137850.
    PubMed     Text format     Abstract available


  215. LIM SM, Choi J, Chang JH, Sohn J, et al
    Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme.
    PLoS One. 2015;10:e0137678.
    PubMed     Text format     Abstract available


  216. WU HB, Wang Z, Wang QS, Han YJ, et al
    Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma.
    PLoS One. 2015;10:e0137676.
    PubMed     Text format     Abstract available


  217. PAL R, Greene S
    microRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma.
    PLoS One. 2015;10:e0137845.
    PubMed     Text format     Abstract available


  218. NIJAGUNA MB, Patil V, Hegde AS, Chandramouli BA, et al
    An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.
    PLoS One. 2015;10:e0137524.
    PubMed     Text format     Abstract available



  219. Correction: REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells.
    PLoS One. 2015;10:e0139645.
    PubMed     Text format     Abstract available


  220. CHENG J, Huang W, Cao S, Yang R, et al
    Enhanced Performance of Brain Tumor Classification via Tumor Region Augmentation and Partition.
    PLoS One. 2015;10:e0140381.
    PubMed     Text format     Abstract available


  221. PERAZZOLI G, Prados J, Ortiz R, Caba O, et al
    Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.
    PLoS One. 2015;10:e0140131.
    PubMed     Text format     Abstract available


  222. LEE Y, Kim KH, Kim DG, Cho HJ, et al
    FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    PLoS One. 2015;10:e0137703.
    PubMed     Text format     Abstract available


  223. WOLPERT F, Happold C, Reifenberger G, Florea AM, et al
    Interferon-beta Modulates the Innate Immune Response against Glioblastoma Initiating Cells.
    PLoS One. 2015;10:e0139603.
    PubMed     Text format     Abstract available


  224. HUSZTHY PC, Sakariassen PO, Espedal H, Brokstad KA, et al
    Correction: Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.
    PLoS One. 2015;10:e0140303.
    PubMed     Text format     Abstract available


  225. MALKOWSKI B, Harat M, Zyromska A, Wisniewski T, et al
    The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET.
    PLoS One. 2015;10:e0140917.
    PubMed     Text format     Abstract available


  226. KWON SM, Kang SH, Park CK, Jung S, et al
    Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
    PLoS One. 2015;10:e0140528.
    PubMed     Text format     Abstract available


  227. CAPPELLARI AR, Pillat MM, Souza HD, Dietrich F, et al
    Ecto-5'-Nucleotidase Overexpression Reduces Tumor Growth in a Xenograph Medulloblastoma Model.
    PLoS One. 2015;10:e0140996.
    PubMed     Text format     Abstract available


  228. LEIDGENS V, Seliger C, Jachnik B, Welz T, et al
    Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms.
    PLoS One. 2015;10:e0140613.
    PubMed     Text format     Abstract available


  229. VERBOVSEK U, Motaln H, Rotter A, Atai NA, et al
    Correction: Expression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in Glioblastoma.
    PLoS One. 2015;10:e0142116.
    PubMed     Text format     Abstract available


  230. YONG WH, Shabihkhani M, Telesca D, Yang S, et al
    Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
    PLoS One. 2015;10:e0141334.
    PubMed     Text format     Abstract available


  231. KLASNER B, Buchmann N, Gempt J, Ringel F, et al
    Early [18F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and Histopathology.
    PLoS One. 2015;10:e0141153.
    PubMed     Text format     Abstract available


  232. ZOMERMAN WW, Plasschaert SL, Diks SH, Lourens HJ, et al
    Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines.
    PLoS One. 2015;10:e0141381.
    PubMed     Text format     Abstract available


  233. BUCK JR, McKinley ET, Fu A, Abel TW, et al
    Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study.
    PLoS One. 2015;10:e0141659.
    PubMed     Text format     Abstract available


  234. THIYAGARAJAN V, Tsai MJ, Weng CF
    Antroquinonol Targets FAK-Signaling Pathway Suppressed Cell Migration, Invasion, and Tumor Growth of C6 Glioma.
    PLoS One. 2015;10:e0141285.
    PubMed     Text format     Abstract available


  235. NAKAE S, Sasaki H, Hayashi S, Hattori N, et al
    PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas.
    PLoS One. 2015;10:e0142750.
    PubMed     Text format     Abstract available


  236. COLOMBO MC, Giverso C, Faggiano E, Boffano C, et al
    Correction: Towards the Personalized Treatment of Glioblastoma: Integrating Patient-Specific Clinical Data in a Continuous Mechanical Model.
    PLoS One. 2015;10:e0143032.
    PubMed     Text format     Abstract available


  237. STAVRINOU P, Mavrogiorgou MC, Polyzoidis K, Kreft-Kerekes V, et al
    Expression Profile of Genes Related to Drug Metabolism in Human Brain Tumors.
    PLoS One. 2015;10:e0143285.
    PubMed     Text format     Abstract available


  238. ZHANG W, Liu Y, Hu H, Huang H, et al
    ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.
    PLoS One. 2015;10:e0142856.
    PubMed     Text format     Abstract available


  239. PAN J, Wang H, Liu X, Hu J, et al
    Tumor Restrictive Suicide Gene Therapy for Glioma Controlled by the FOS Promoter.
    PLoS One. 2015;10:e0143112.
    PubMed     Text format     Abstract available


  240. HAN L, Liu D, Li Z, Tian N, et al
    HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.
    PLoS One. 2015;10:e0142387.
    PubMed     Text format     Abstract available


  241. ROMANETS-KORBUT O, Najakshin AM, Yurchenko M, Malysheva TA, et al
    Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.
    PLoS One. 2015;10:e0118302.
    PubMed     Text format     Abstract available


  242. HU LS, Ning S, Eschbacher JM, Gaw N, et al
    Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma.
    PLoS One. 2015;10:e0141506.
    PubMed     Text format     Abstract available


  243. SHEN Y, Chen H, Zhang J, Chen Y, et al
    Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor Cells.
    PLoS One. 2015;10:e0142594.
    PubMed     Text format     Abstract available


  244. CHENG J, Huang W, Cao S, Yang R, et al
    Correction: Enhanced Performance of Brain Tumor Classification via Tumor Region Augmentation and Partition.
    PLoS One. 2015;10:e0144479.
    PubMed     Text format     Abstract available


  245. LOBO MR, Kukino A, Tran H, Schabel MC, et al
    Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma.
    PLoS One. 2015;10:e0144488.
    PubMed     Text format     Abstract available


  246. GARNER JM, Ellison DW, Finkelstein D, Ganguly D, et al
    Correction: Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline Is Regulated by Different Cancer Stem Cell Populations.
    PLoS One. 2015;10:e0145052.
    PubMed     Text format     Abstract available


  247. JOSEPH JV, Roosmalen IA, Busschers E, Tomar T, et al
    Serum-Induced Differentiation of Glioblastoma Neurospheres Leads to Enhanced Migration/Invasion Capacity That Is Associated with Increased MMP9.
    PLoS One. 2015;10:e0145393.
    PubMed     Text format     Abstract available


  248. DENES J, Kasuki L, Trivellin G, Colli LM, et al
    Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.
    PLoS One. 2015;10:e0117107.
    PubMed     Text format     Abstract available


  249. GEORGES JF, Liu X, Eschbacher J, Nichols J, et al
    Use of a Conformational Switching Aptamer for Rapid and Specific Ex Vivo Identification of Central Nervous System Lymphoma in a Xenograft Model.
    PLoS One. 2015;10:e0123607.
    PubMed     Text format     Abstract available


  250. WILHELM-BUCHSTAB T, Buchstab BM, Leitzen C, Garbe S, et al
    Extraretinal induced visual sensations during IMRT of the brain.
    PLoS One. 2015;10:e0123440.
    PubMed     Text format     Abstract available


  251. TOHTI M, Li J, Zhou Y, Hu Y, et al
    Is peri-operative steroid replacement therapy necessary for the pituitary adenomas treated with surgery? A systematic review and meta analysis.
    PLoS One. 2015;10:e0119621.
    PubMed     Text format     Abstract available


  252. MIYAZAKI M, Ouyang C, Zhou X, Murdoch JB, et al
    Z-Spectrum analysis provides proton environment data (ZAPPED): a new two-pool technique for human gray and white matter.
    PLoS One. 2015;10:e0119915.
    PubMed     Text format     Abstract available


  253. SIE M, den Dunnen WF, Lourens HJ, Meeuwsen-de Boer TG, et al
    Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma.
    PLoS One. 2015;10:e0122555.
    PubMed     Text format     Abstract available


  254. CHENG S, Gomez K, Serri O, Chik C, et al
    The role of diabetes in acromegaly associated neoplasia.
    PLoS One. 2015;10:e0127276.
    PubMed     Text format     Abstract available


  255. FERNANDEZ-PALOMO C, Mothersill C, Brauer-Krisch E, Laissue J, et al
    gamma-H2AX as a marker for dose deposition in the brain of wistar rats after synchrotron microbeam radiation.
    PLoS One. 2015;10:e0119924.
    PubMed     Text format     Abstract available


  256. CHEN YM, Lai CH, Chang HC, Chao TY, et al
    Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    PLoS One. 2015;10:e0136252.
    PubMed     Text format     Abstract available


  257. KHURANA H, Meena VK, Prakash S, Chuttani K, et al
    Preclinical Evaluation of a Potential GSH Ester Based PET/SPECT Imaging Probe DT(GSHMe)2 to Detect Gamma Glutamyl Transferase Over Expressing Tumors.
    PLoS One. 2015;10:e0134281.
    PubMed     Text format     Abstract available


  258. JUNG YY, Kim HM, Koo JS
    Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
    PLoS One. 2015;10:e0137204.
    PubMed     Text format     Abstract available


    January 2014
  259. XIE SS, Li M, Zhou CC, Song XL, et al
    Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis.
    PLoS One. 2014;9:e103431.
    PubMed     Text format     Abstract available


  260. GILL KZ, Iwamoto F, Allen A, Hoehn D, et al
    MYC Protein Expression in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
    PLoS One. 2014;9:e114398.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: